| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Antitumor in situ vaccination effect of TNFα and IL-12 plasmid DNA electrotransfer in a murine melanoma model
|
Kamensek, Urska
|
|
2018
|
67 |
5 |
p. 785-795
|
artikel
|
| 2 |
Cancer immunotherapy in patients with brain metastases
|
Caponnetto, Salvatore
|
|
2018
|
67 |
5 |
p. 703-711
|
artikel
|
| 3 |
Certain BCG-reactive responses are associated with bladder cancer prognosis
|
Shan, Guang
|
|
2018
|
67 |
5 |
p. 797-803
|
artikel
|
| 4 |
Chimeric antigen receptors with human scFvs preferentially induce T cell anti-tumor activity against tumors with high B7H6 expression
|
Gacerez, Albert T.
|
|
2018
|
67 |
5 |
p. 749-759
|
artikel
|
| 5 |
Chronic lymphocytic leukemia cells acquire regulatory B-cell properties in response to TLR9 and CD40 activation
|
Ringelstein-Harlev, Shimrit
|
|
2018
|
67 |
5 |
p. 739-748
|
artikel
|
| 6 |
Early detection of hepatocellular carcinoma using autoantibody profiles from a panel of tumor-associated antigens
|
Koziol, James A.
|
|
2018
|
67 |
5 |
p. 835-841
|
artikel
|
| 7 |
Identification of tumor-reactive B cells and systemic IgG in breast cancer based on clonal frequency in the sentinel lymph node
|
McDaniel, Jonathan R.
|
|
2018
|
67 |
5 |
p. 729-738
|
artikel
|
| 8 |
Impaired lymphocyte function in patients with hepatic malignancies after selective internal radiotherapy
|
Domouchtsidou, Aglaia
|
|
2018
|
67 |
5 |
p. 843-853
|
artikel
|
| 9 |
Ipilimumab in metastatic melanoma patients with pre-existing autoimmune disorders
|
Kähler, Katharina C.
|
|
2018
|
67 |
5 |
p. 825-834
|
artikel
|
| 10 |
PD-L1, B7-H3, and PD-1 expression in immunocompetent vs. immunosuppressed patients with cutaneous squamous cell carcinoma
|
Varki, Vinod
|
|
2018
|
67 |
5 |
p. 805-814
|
artikel
|
| 11 |
Pretreatment neutrophil-to-lymphocyte ratio is associated with outcome of advanced-stage cancer patients treated with immunotherapy: a meta-analysis
|
Jiang, Tao
|
|
2018
|
67 |
5 |
p. 713-727
|
artikel
|
| 12 |
The BCR-ABL inhibitor nilotinib influences phenotype and function of monocyte-derived human dendritic cells
|
Dörfel, Daniela
|
|
2018
|
67 |
5 |
p. 775-783
|
artikel
|
| 13 |
The multi-receptor inhibitor axitinib reverses tumor-induced immunosuppression and potentiates treatment with immune-modulatory antibodies in preclinical murine models
|
Läubli, Heinz
|
|
2018
|
67 |
5 |
p. 815-824
|
artikel
|
| 14 |
The Third Institute for Cancer Vaccines and Immunotherapy (ICVI) symposium on immunotherapy: May 12–13, 2017, Royal Society, London, UK
|
Dalgleish, Angus G
|
|
2018
|
67 |
5 |
p. 855-860
|
artikel
|
| 15 |
TriCurin, a synergistic formulation of curcumin, resveratrol, and epicatechin gallate, repolarizes tumor-associated macrophages and triggers an immune response to cause suppression of HPV+ tumors
|
Mukherjee, Sumit
|
|
2018
|
67 |
5 |
p. 761-774
|
artikel
|
Tijdschrift beschrijving